Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
for
Crohns Disease
Location: Hamilton, London, Cleveland OH, St Louis MO,
Sponsor: Alimentiv Inc.
Sex: All
Age: 18+
Code: NCT06670638
Recruiting
Active & Responsive
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Get alerts for new trials in your area by subscribing now
Active & Responsive
Treatment of Moderate to Severe Refractory Crohn's Disease
for
Crohns Disease
Location: New York NY, Gainesville FL, Cleveland OH, Ann Arbor MI,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18 - 65
Code: NCT06721962
Phase1, Phase2, Recruiting
Active & Responsive
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Boston MA, New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237516
Recruiting
Active & Responsive
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
for
Perianal Fistula Due to Crohn's Disease
Location: New York NY, St Louis MO, Aurora CO
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT06918808
Phase2, Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Halifax, Providence RI, New York NY, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Boston MA, Providence RI, North Massapequa NY,